SlideShare uma empresa Scribd logo
1 de 9
Rohin Khanna
   2 Classes of antipsychotics
     Typical / Conventional
      ▪ Block Dopamine D2 receptors
      ▪ Work on +ve symptoms (hallucinations/delusions)
     Atypical / Novel
      ▪ Block serotonin and dopamine receptors
      ▪ Also M3 (olanzapine), H1 (quetiapine), α, D4 (clozapine)
      ▪ Work on +ve and –ve symptoms (blunted affect, poverty
        of speech, anhedonia)
   Conventional/Typical                 Usual Dose, PO/D, mg
     Low Potency
      ▪ Chlorpromazine (Thorazine)         ▪ 100-1000 (IM)
      ▪ Thioridazine (Mellaril)            ▪ 100-800
     Mid Potency
      ▪ Trifluoperazine (Stelazine)        ▪ 2-15
      ▪ Perphenazine (Trilafon)            ▪ 4-32
     High Potency
      ▪ Haloperidol (Haldol)               ▪ 0.5-10 (IM)
      ▪ Fluphenazine (Prolixin)            ▪ 1-10 (IM)
      ▪ Thiothixene (Navane)               ▪ 2-20
   High Potency
     Least sedating
     Have no anticholinergic symptoms (dry mouth,
      constipation, hot, dry skin, tachycardia, delirium in elderly)
     High tendency for EPS
   Low Potency
     Most sedating
     Have more anticholinergic symptoms
     Lower tendency for EPS
   Mid Potency
     Well tolerated
   Novel /Atypical                Usual Dose, PO/D, mg
     Clozapine (Clozaril)           200-600
     Risperidone (Risperdal)        2-6
     Olanzapine (Zyprexa)           10-20 (IM)
     Quietapine (Seraquel)          300-400
     Aripiprazole (Abilify)         10-30 (IM)
     Ziprasidone (Geodon)           20-80 (IM)
   Tend not to induce EPS
   Weight gain, induce onset DM (exp
    clozapine, olanzapine)
   Other SE, drooling, sedation, amenorrhea
   Clozapine may cause agranulocytosis
     WBC/ANC baseline
     qWk 6 months, q2wk 6 months, q4wk > 1 year
     Continue for qwk 1 month after d/c
   EPS
     Begin several hours to weeks of start treatment
     Include acute dystonia (muscle spasm, stiffness), akinesia
      (parkinsonian-like, decreased movements), akathisia
      (restlessness, increased movements), tardive dyskinesia
      (facial, distal extremities involuntary movements)
   NMS
     Hyperpyrexia, muscle rigidity, agitation, increased
      WBC/CK/myoglobinuria
     Tx= supportive, dantrolene (muscle relaxant, binds
      ryanodine rec, dec Ca2+), bromocriptine (dopamine
      agonist)
   Braunwald, E., et al. (2002). Harrison’s manual of medicine.
    International Edition: McGraw Hill.
   Bhushan, V., Le, T. (2011). First Aid for the USMLE Step 1
    2011: A Student to student guide. McGraw Hill.
   Jann MW, Grimsley SR, Gray EC, Chang WH.
    Pharmacokinetics and pharmacodynamics of clozapine. Clin
    Pharmacokinet 1993; 24:161.
Antipsychotic medications

Mais conteúdo relacionado

Destaque

Terms in psychiatry
Terms in psychiatryTerms in psychiatry
Terms in psychiatry
Juby Raju
 
Anti-depressants - Selective Serotonin Re-uptake Inhibitors (SSRIs)
Anti-depressants - Selective Serotonin Re-uptake Inhibitors (SSRIs)Anti-depressants - Selective Serotonin Re-uptake Inhibitors (SSRIs)
Anti-depressants - Selective Serotonin Re-uptake Inhibitors (SSRIs)
Marium Saeed
 
Therapeutics mcq 200
Therapeutics mcq 200Therapeutics mcq 200
Therapeutics mcq 200
Dennis George
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
raj kumar
 
Anti depressant and its classifications
Anti depressant and its classificationsAnti depressant and its classifications
Anti depressant and its classifications
Natasha Puri
 
Fuck You 333 Photos 1200433382899561 4
Fuck You 333 Photos 1200433382899561 4Fuck You 333 Photos 1200433382899561 4
Fuck You 333 Photos 1200433382899561 4
pascal fox
 

Destaque (18)

Anxiety presentation
Anxiety presentationAnxiety presentation
Anxiety presentation
 
Highlight on bipolar depression mohamed sedky 2014
Highlight on bipolar depression  mohamed sedky  2014Highlight on bipolar depression  mohamed sedky  2014
Highlight on bipolar depression mohamed sedky 2014
 
Quiz on pharmacology
Quiz on pharmacologyQuiz on pharmacology
Quiz on pharmacology
 
Comparison Of Drug Tx & Psycotherapy in the treatment of Depression
Comparison Of Drug Tx & Psycotherapy in the treatment of DepressionComparison Of Drug Tx & Psycotherapy in the treatment of Depression
Comparison Of Drug Tx & Psycotherapy in the treatment of Depression
 
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig UniversityHistology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
 
Terms in psychiatry
Terms in psychiatryTerms in psychiatry
Terms in psychiatry
 
Pharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's DiseasePharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's Disease
 
Psychiatric Disorders: History. Classification. Prevalence. Comorbidity. Epid...
Psychiatric Disorders: History. Classification. Prevalence. Comorbidity. Epid...Psychiatric Disorders: History. Classification. Prevalence. Comorbidity. Epid...
Psychiatric Disorders: History. Classification. Prevalence. Comorbidity. Epid...
 
Anti-depressants - Selective Serotonin Re-uptake Inhibitors (SSRIs)
Anti-depressants - Selective Serotonin Re-uptake Inhibitors (SSRIs)Anti-depressants - Selective Serotonin Re-uptake Inhibitors (SSRIs)
Anti-depressants - Selective Serotonin Re-uptake Inhibitors (SSRIs)
 
Therapeutics mcq 200
Therapeutics mcq 200Therapeutics mcq 200
Therapeutics mcq 200
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Schizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic DrugsSchizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic Drugs
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Pharmacology MCQ with Solution
Pharmacology MCQ with SolutionPharmacology MCQ with Solution
Pharmacology MCQ with Solution
 
Anti depressant and its classifications
Anti depressant and its classificationsAnti depressant and its classifications
Anti depressant and its classifications
 
Bipolar disorder
Bipolar disorderBipolar disorder
Bipolar disorder
 
Fuck You 333 Photos 1200433382899561 4
Fuck You 333 Photos 1200433382899561 4Fuck You 333 Photos 1200433382899561 4
Fuck You 333 Photos 1200433382899561 4
 
Bipolar Disorder
Bipolar DisorderBipolar Disorder
Bipolar Disorder
 

Semelhante a Antipsychotic medications

Breaking Barriers and Improving Treatment Outcomes in Schizophrenia (YMPS-IMU...
Breaking Barriers and Improving Treatment Outcomes in Schizophrenia (YMPS-IMU...Breaking Barriers and Improving Treatment Outcomes in Schizophrenia (YMPS-IMU...
Breaking Barriers and Improving Treatment Outcomes in Schizophrenia (YMPS-IMU...
Laura Kho Sui San, RPh, BCPP
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
Jaymax13
 
An update on psychopharmacology
An update on psychopharmacology An update on psychopharmacology
An update on psychopharmacology
Pk Doctors
 
An update on psychopharmacology part i 22 june 2007 fountain house
An update on psychopharmacology part i 22 june 2007 fountain houseAn update on psychopharmacology part i 22 june 2007 fountain house
An update on psychopharmacology part i 22 june 2007 fountain house
Pk Doctors
 

Semelhante a Antipsychotic medications (20)

Breaking Barriers and Improving Treatment Outcomes in Schizophrenia (YMPS-IMU...
Breaking Barriers and Improving Treatment Outcomes in Schizophrenia (YMPS-IMU...Breaking Barriers and Improving Treatment Outcomes in Schizophrenia (YMPS-IMU...
Breaking Barriers and Improving Treatment Outcomes in Schizophrenia (YMPS-IMU...
 
Antipsychotics and updates
Antipsychotics and updatesAntipsychotics and updates
Antipsychotics and updates
 
Psychiatric drug
Psychiatric drugPsychiatric drug
Psychiatric drug
 
Obat psikosis
Obat psikosisObat psikosis
Obat psikosis
 
Review Primary Care
Review Primary CareReview Primary Care
Review Primary Care
 
Schizophrenia1
Schizophrenia1Schizophrenia1
Schizophrenia1
 
Ati 2
Ati 2Ati 2
Ati 2
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Parkinson's Disease by Dr. Aryan
Parkinson's Disease by Dr. AryanParkinson's Disease by Dr. Aryan
Parkinson's Disease by Dr. Aryan
 
Antipsychotic Drugs "Typical and Atypical"
Antipsychotic Drugs "Typical and Atypical" Antipsychotic Drugs "Typical and Atypical"
Antipsychotic Drugs "Typical and Atypical"
 
ASandler_PD_Topic Discussion_8_30.docx
ASandler_PD_Topic Discussion_8_30.docxASandler_PD_Topic Discussion_8_30.docx
ASandler_PD_Topic Discussion_8_30.docx
 
Psychiatric medication and its importance
Psychiatric  medication and its importancePsychiatric  medication and its importance
Psychiatric medication and its importance
 
Management of antipsychotic overdose
Management of antipsychotic overdoseManagement of antipsychotic overdose
Management of antipsychotic overdose
 
Typical antipsychotics and dopamine in psychosis
Typical antipsychotics and dopamine in psychosis Typical antipsychotics and dopamine in psychosis
Typical antipsychotics and dopamine in psychosis
 
An update on psychopharmacology
An update on psychopharmacology An update on psychopharmacology
An update on psychopharmacology
 
An update on psychopharmacology part i 22 june 2007 fountain house
An update on psychopharmacology part i 22 june 2007 fountain houseAn update on psychopharmacology part i 22 june 2007 fountain house
An update on psychopharmacology part i 22 june 2007 fountain house
 
Drug induced movement disorders
Drug induced movement disordersDrug induced movement disorders
Drug induced movement disorders
 
Pain control in ED 2010
Pain control in ED 2010Pain control in ED 2010
Pain control in ED 2010
 
Movemet disorders
Movemet disordersMovemet disorders
Movemet disorders
 
Antimanic agents
Antimanic agentsAntimanic agents
Antimanic agents
 

Mais de discoverccs-org

Mais de discoverccs-org (19)

Psychiatric medication paec november 2013
Psychiatric medication paec november 2013Psychiatric medication paec november 2013
Psychiatric medication paec november 2013
 
Neuropsychiatric manifestations of systematic lupus
Neuropsychiatric manifestations of systematic lupusNeuropsychiatric manifestations of systematic lupus
Neuropsychiatric manifestations of systematic lupus
 
Trichotillomania
TrichotillomaniaTrichotillomania
Trichotillomania
 
Sensation and perception
Sensation and perceptionSensation and perception
Sensation and perception
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Psychopathy
PsychopathyPsychopathy
Psychopathy
 
Intelligence
IntelligenceIntelligence
Intelligence
 
Human development
Human developmentHuman development
Human development
 
Conditioning and learning
Conditioning and learningConditioning and learning
Conditioning and learning
 
Cognition, learning and creativity
Cognition, learning and creativityCognition, learning and creativity
Cognition, learning and creativity
 
Bath Salts Intoxication
Bath Salts IntoxicationBath Salts Intoxication
Bath Salts Intoxication
 
Generalized anxiety disorder
Generalized anxiety disorderGeneralized anxiety disorder
Generalized anxiety disorder
 
Reactive attachment disorder_presentation_psych_dr.martinez
Reactive attachment disorder_presentation_psych_dr.martinezReactive attachment disorder_presentation_psych_dr.martinez
Reactive attachment disorder_presentation_psych_dr.martinez
 
Body dysmorphic disorder
Body dysmorphic disorderBody dysmorphic disorder
Body dysmorphic disorder
 
Heroin addiction
Heroin addictionHeroin addiction
Heroin addiction
 
Misophonia
MisophoniaMisophonia
Misophonia
 
Rett syndrome
Rett syndromeRett syndrome
Rett syndrome
 
Post partum presentation
Post partum presentationPost partum presentation
Post partum presentation
 
Mood disorders
Mood disordersMood disorders
Mood disorders
 

Antipsychotic medications

  • 2. 2 Classes of antipsychotics  Typical / Conventional ▪ Block Dopamine D2 receptors ▪ Work on +ve symptoms (hallucinations/delusions)  Atypical / Novel ▪ Block serotonin and dopamine receptors ▪ Also M3 (olanzapine), H1 (quetiapine), α, D4 (clozapine) ▪ Work on +ve and –ve symptoms (blunted affect, poverty of speech, anhedonia)
  • 3. Conventional/Typical  Usual Dose, PO/D, mg  Low Potency ▪ Chlorpromazine (Thorazine) ▪ 100-1000 (IM) ▪ Thioridazine (Mellaril) ▪ 100-800  Mid Potency ▪ Trifluoperazine (Stelazine) ▪ 2-15 ▪ Perphenazine (Trilafon) ▪ 4-32  High Potency ▪ Haloperidol (Haldol) ▪ 0.5-10 (IM) ▪ Fluphenazine (Prolixin) ▪ 1-10 (IM) ▪ Thiothixene (Navane) ▪ 2-20
  • 4. High Potency  Least sedating  Have no anticholinergic symptoms (dry mouth, constipation, hot, dry skin, tachycardia, delirium in elderly)  High tendency for EPS  Low Potency  Most sedating  Have more anticholinergic symptoms  Lower tendency for EPS  Mid Potency  Well tolerated
  • 5. Novel /Atypical  Usual Dose, PO/D, mg  Clozapine (Clozaril)  200-600  Risperidone (Risperdal)  2-6  Olanzapine (Zyprexa)  10-20 (IM)  Quietapine (Seraquel)  300-400  Aripiprazole (Abilify)  10-30 (IM)  Ziprasidone (Geodon)  20-80 (IM)
  • 6. Tend not to induce EPS  Weight gain, induce onset DM (exp clozapine, olanzapine)  Other SE, drooling, sedation, amenorrhea  Clozapine may cause agranulocytosis  WBC/ANC baseline  qWk 6 months, q2wk 6 months, q4wk > 1 year  Continue for qwk 1 month after d/c
  • 7. EPS  Begin several hours to weeks of start treatment  Include acute dystonia (muscle spasm, stiffness), akinesia (parkinsonian-like, decreased movements), akathisia (restlessness, increased movements), tardive dyskinesia (facial, distal extremities involuntary movements)  NMS  Hyperpyrexia, muscle rigidity, agitation, increased WBC/CK/myoglobinuria  Tx= supportive, dantrolene (muscle relaxant, binds ryanodine rec, dec Ca2+), bromocriptine (dopamine agonist)
  • 8. Braunwald, E., et al. (2002). Harrison’s manual of medicine. International Edition: McGraw Hill.  Bhushan, V., Le, T. (2011). First Aid for the USMLE Step 1 2011: A Student to student guide. McGraw Hill.  Jann MW, Grimsley SR, Gray EC, Chang WH. Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet 1993; 24:161.

Notas do Editor

  1. Agran- wbc count below 2000cells/mm3 blood (<5% of normal)